Three H2i Ventures Named on 2023 Forbes 30 Under 30 Toronto

Congratulations to HDAX Therapeutics, Mind-Easy & MyoPalate for being name on the 2023 Forbes 30 Under 30 Local List for Toronto! 

One of ten local lists for cities across North America, the Forbes 30 Under 30 Local List for Toronto highlights the work of 30 incredible young leaders who are creating remarkable change across sectors. H2i was excited to see three ventures from our community recognized for their hard-work, innovation, impact and leadership.

HDAX Therapeutics Co-Founders Pimyupa Manaswiyoungkul and Nabanita Nawar earned a place on the list for their work creating the first ever therapy for peripheral neuropathy.

“We’re extremely honoured and humbled to be recognized as Forbes 30 Under 30 in Toronto. This recognition offers us a valuable platform to showcase the progress we’ve made at HDAX Therapeutics, bringing us one step closer to addressing unmet clinical needs. None of this would have been possible without the nomination from H2i’s very own, Prof Paul Santerre.” 
Nabanita Nawar, Co-Founder & CEO, HDAX Therapeutics

Mind-Easy Co-Founders Dalia Ahmed, Alexandra Assouad and Akanksha Shelat were recognized for their AI-driven mental health platform that delivers innovative, culturally competent care.

“It’s an immense honor for our team to be recognized by Forbes 30 Under 30. This achievement is a testament to our team’s relentless dedication to reshaping mental health solutions and fostering positive change in workplaces everywhere.” Alexandra Assouad, Co-Founder & CEO, Mind-Easy

Myo Palate Co-Founders Charlie Hua and Frank Yu were named on the list for their work using regenerative medicine techniques to bring about a new, climate-friendly era of protein consumption.

“We are honored to join the Forbes list and even more grateful for our communities that got us here. We look forward to making continued contributions to Toronto’s biotech sector in the years ahead.” – Frank Yu, Co-Founder, Myo Palate